Answers are grounded in this paper and cite their sources.
We investigated the influence of the extract of soy protein fermented with lactic acid bacteria and yeast (ESFL) on 1, 2-dimethylhydrazine (DMH)-induced colon cancer and aberrant crypt foci (ACF) in ICR female mice. In all the experiments, 8-week old mice were given subcutaneous DMH injections at 35 mg/kg once a week. In the experiment for colon cancer, mice were divided into groups A, B and C, with 20 mice each, and groups A and B were given DMHinjections for 10 weeks. Group C were injected with only PBS. Group A were fed a 5%-ESFL diet and groups B and C were fed normal mouse diets throughout the experiment for 35 weeks. Group A showed a 28.5% inhibition in incidence and a 59.1% inhibition in average number of tumors compared to group B, but the results were not statistically significant. In ACF experiments, mice were divided into 4 groups, 10%-ESFL group, 1%-ESFL group, 0.1%-ESFL group, and a control with 10 mice each. All the mice were given DMH injections for 4 weeks. ESFL-supplemented diets were given throughout the experiment for 8 weeks. ACF formation decreased in all the ESFL-fed groups in a dose-dependent manner and the results were statistically significant in the 10%-ESFL group (69% inhibition, p<0.001) and 1%-ESFL group (40% inhibition, p<0.05) compared to the control. The present study suggests that ESFL could contain an effective anticarcinogenic substance (s).
No takes yet. Share an insight, caveat, or question.
KITAJYO et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: